Logo image of VUZI

VUZIX CORP (VUZI) Stock Fundamental Analysis

NASDAQ:VUZI - Nasdaq - US92921W3007 - Common Stock - Currency: USD

3.29  -0.4 (-10.84%)

After market: 3.34 +0.05 (+1.52%)

Fundamental Rating

3

Overall VUZI gets a fundamental rating of 3 out of 10. We evaluated VUZI against 124 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for VUZI as it has an excellent financial health rating, but there are worries on the profitability. VUZI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year VUZI has reported negative net income.
VUZI had a negative operating cash flow in the past year.
VUZI had negative earnings in each of the past 5 years.
In the past 5 years VUZI always reported negative operating cash flow.
VUZI Yearly Net Income VS EBIT VS OCF VS FCFVUZI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M -50M

1.2 Ratios

The Return On Assets of VUZI (-190.61%) is worse than 97.50% of its industry peers.
The Return On Equity of VUZI (-201.66%) is worse than 92.50% of its industry peers.
Industry RankSector Rank
ROA -190.61%
ROE -201.66%
ROIC N/A
ROA(3y)-38.74%
ROA(5y)-50.87%
ROE(3y)-41.7%
ROE(5y)-56.78%
ROIC(3y)N/A
ROIC(5y)N/A
VUZI Yearly ROA, ROE, ROICVUZI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

VUZI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VUZI Yearly Profit, Operating, Gross MarginsVUZI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

8

2. Health

2.1 Basic Checks

VUZI does not have a ROIC to compare to the WACC, probably because it is not profitable.
VUZI has more shares outstanding than it did 1 year ago.
VUZI has more shares outstanding than it did 5 years ago.
There is no outstanding debt for VUZI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VUZI Yearly Shares OutstandingVUZI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
VUZI Yearly Total Debt VS Total AssetsVUZI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

An Altman-Z score of 48.61 indicates that VUZI is not in any danger for bankruptcy at the moment.
The Altman-Z score of VUZI (48.61) is better than 99.17% of its industry peers.
VUZI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 48.61
ROIC/WACCN/A
WACC9.06%
VUZI Yearly LT Debt VS Equity VS FCFVUZI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

A Current Ratio of 13.16 indicates that VUZI has no problem at all paying its short term obligations.
VUZI's Current ratio of 13.16 is amongst the best of the industry. VUZI outperforms 95.83% of its industry peers.
VUZI has a Quick Ratio of 8.66. This indicates that VUZI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 8.66, VUZI belongs to the top of the industry, outperforming 94.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.16
Quick Ratio 8.66
VUZI Yearly Current Assets VS Current LiabilitesVUZI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

VUZI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.62%.
VUZI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -60.25%.
VUZI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.44% yearly.
EPS 1Y (TTM)-15.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.65%
Revenue 1Y (TTM)-60.25%
Revenue growth 3Y1.56%
Revenue growth 5Y8.44%
Sales Q2Q%-36.44%

3.2 Future

VUZI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.65% yearly.
The Revenue is expected to decrease by -21.65% on average over the next years. This is quite bad
EPS Next Y-36%
EPS Next 2Y16.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-54.53%
Revenue Next 2Y-21.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VUZI Yearly Revenue VS EstimatesVUZI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
VUZI Yearly EPS VS EstimatesVUZI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VUZI. In the last year negative earnings were reported.
Also next year VUZI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VUZI Price Earnings VS Forward Price EarningsVUZI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VUZI Per share dataVUZI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6

4.3 Compensation for Growth

A more expensive valuation may be justified as VUZI's earnings are expected to grow with 16.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.65%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

VUZI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VUZIX CORP

NASDAQ:VUZI (2/21/2025, 8:00:01 PM)

After market: 3.34 +0.05 (+1.52%)

3.29

-0.4 (-10.84%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)03-12 2025-03-12/amc
Inst Owners16.58%
Inst Owner Change-95.29%
Ins Owners6.95%
Ins Owner Change-0.14%
Market Cap242.21M
Analysts82.86
Price Target2.04 (-37.99%)
Short Float %19.59%
Short Ratio4.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-35.62%
Min EPS beat(2)-56.86%
Max EPS beat(2)-14.38%
EPS beat(4)0
Avg EPS beat(4)-44.84%
Min EPS beat(4)-96.08%
Max EPS beat(4)-12.04%
EPS beat(8)1
Avg EPS beat(8)-23.51%
EPS beat(12)2
Avg EPS beat(12)-25.59%
EPS beat(16)3
Avg EPS beat(16)-22.03%
Revenue beat(2)0
Avg Revenue beat(2)-44.48%
Min Revenue beat(2)-58.04%
Max Revenue beat(2)-30.92%
Revenue beat(4)0
Avg Revenue beat(4)-39.79%
Min Revenue beat(4)-58.04%
Max Revenue beat(4)-18.7%
Revenue beat(8)2
Avg Revenue beat(8)-27.73%
Revenue beat(12)2
Avg Revenue beat(12)-22.72%
Revenue beat(16)4
Avg Revenue beat(16)-20.29%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-30.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 43.65
P/FCF N/A
P/OCF N/A
P/B 6.12
P/tB 6.81
EV/EBITDA N/A
EPS(TTM)-0.74
EYN/A
EPS(NY)-0.48
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS0.08
BVpS0.54
TBVpS0.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -190.61%
ROE -201.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-38.74%
ROA(5y)-50.87%
ROE(3y)-41.7%
ROE(5y)-56.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 96.51%
Cap/Sales 79.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.16
Quick Ratio 8.66
Altman-Z 48.61
F-Score3
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)424.91%
Cap/Depr(5y)289.15%
Cap/Sales(3y)110.98%
Cap/Sales(5y)77.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.65%
EPS Next Y-36%
EPS Next 2Y16.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-60.25%
Revenue growth 3Y1.56%
Revenue growth 5Y8.44%
Sales Q2Q%-36.44%
Revenue Next Year-54.53%
Revenue Next 2Y-21.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.56%
OCF growth 3YN/A
OCF growth 5YN/A